The primitive state of quality measures in addiction treatment and their application.
Identifieur interne : 000B32 ( Main/Exploration ); précédent : 000B31; suivant : 000B33The primitive state of quality measures in addiction treatment and their application.
Auteurs : Alex H S. Harris [États-Unis]Source :
- Addiction (Abingdon, England) [ 1360-0443 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Troubles liés à une substance.
- normes : Qualité des soins de santé.
- thérapie : Troubles liés à une substance.
- Codage clinique, Humains, Indicateurs qualité santé.
English descriptors
- KwdEn :
- MESH :
- diagnosis : Substance-Related Disorders.
- standards : Quality of Health Care.
- therapy : Substance-Related Disorders.
- Clinical Coding, Humans, Quality Indicators, Health Care.
Abstract
Developing quality measures in addiction treatment and implementing them is easy. Developing ones that are valid, interpretable, that motivate real improvements in quality and do not have adverse unintended consequences is very difficult. One serious, but mostly unacknowledged, threat to the validity of quality measures is poor estimates of the true prevalence of substance use disorder in a target population, leading to errors in estimates of treatment coverage.
DOI: 10.1111/add.13096
PubMed: 26395364
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The primitive state of quality measures in addiction treatment and their application.</title>
<author><name sortKey="Harris, Alex H S" sort="Harris, Alex H S" uniqKey="Harris A" first="Alex H S" last="Harris">Alex H S. Harris</name>
<affiliation wicri:level="1"><nlm:affiliation>Center for Innovation to Implementation, VA Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, 94025, USA. alexander.harris2@va.gov.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Innovation to Implementation, VA Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, 94025</wicri:regionArea>
<wicri:noRegion>94025</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26395364</idno>
<idno type="pmid">26395364</idno>
<idno type="doi">10.1111/add.13096</idno>
<idno type="wicri:Area/Main/Corpus">000E07</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000E07</idno>
<idno type="wicri:Area/Main/Curation">000E07</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000E07</idno>
<idno type="wicri:Area/Main/Exploration">000E07</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The primitive state of quality measures in addiction treatment and their application.</title>
<author><name sortKey="Harris, Alex H S" sort="Harris, Alex H S" uniqKey="Harris A" first="Alex H S" last="Harris">Alex H S. Harris</name>
<affiliation wicri:level="1"><nlm:affiliation>Center for Innovation to Implementation, VA Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, 94025, USA. alexander.harris2@va.gov.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Innovation to Implementation, VA Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, 94025</wicri:regionArea>
<wicri:noRegion>94025</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Addiction (Abingdon, England)</title>
<idno type="eISSN">1360-0443</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Clinical Coding (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Quality Indicators, Health Care (MeSH)</term>
<term>Quality of Health Care (standards)</term>
<term>Substance-Related Disorders (diagnosis)</term>
<term>Substance-Related Disorders (therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Codage clinique (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Indicateurs qualité santé (MeSH)</term>
<term>Qualité des soins de santé (normes)</term>
<term>Troubles liés à une substance (diagnostic)</term>
<term>Troubles liés à une substance (thérapie)</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Troubles liés à une substance</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Qualité des soins de santé</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Quality of Health Care</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Troubles liés à une substance</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Clinical Coding</term>
<term>Humans</term>
<term>Quality Indicators, Health Care</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Codage clinique</term>
<term>Humains</term>
<term>Indicateurs qualité santé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Developing quality measures in addiction treatment and implementing them is easy. Developing ones that are valid, interpretable, that motivate real improvements in quality and do not have adverse unintended consequences is very difficult. One serious, but mostly unacknowledged, threat to the validity of quality measures is poor estimates of the true prevalence of substance use disorder in a target population, leading to errors in estimates of treatment coverage. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26395364</PMID>
<DateCompleted><Year>2017</Year>
<Month>01</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>06</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1360-0443</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>111</Volume>
<Issue>2</Issue>
<PubDate><Year>2016</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Addiction (Abingdon, England)</Title>
<ISOAbbreviation>Addiction</ISOAbbreviation>
</Journal>
<ArticleTitle>The primitive state of quality measures in addiction treatment and their application.</ArticleTitle>
<Pagination><MedlinePgn>195-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/add.13096</ELocationID>
<Abstract><AbstractText>Developing quality measures in addiction treatment and implementing them is easy. Developing ones that are valid, interpretable, that motivate real improvements in quality and do not have adverse unintended consequences is very difficult. One serious, but mostly unacknowledged, threat to the validity of quality measures is poor estimates of the true prevalence of substance use disorder in a target population, leading to errors in estimates of treatment coverage. </AbstractText>
<CopyrightInformation>Published 2015. This article is a U.S. Government work and is in the public domain in the USA.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harris</LastName>
<ForeName>Alex H S</ForeName>
<Initials>AH</Initials>
<AffiliationInfo><Affiliation>Center for Innovation to Implementation, VA Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, 94025, USA. alexander.harris2@va.gov.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>I01 HX000517</GrantID>
<Acronym>HX</Acronym>
<Agency>HSRD VA</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>IK6 HX002840</GrantID>
<Acronym>HX</Acronym>
<Agency>HSRD VA</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>09</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Addiction</MedlineTA>
<NlmUniqueID>9304118</NlmUniqueID>
<ISSNLinking>0965-2140</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D059019" MajorTopicYN="N">Clinical Coding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019984" MajorTopicYN="N">Quality Indicators, Health Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011787" MajorTopicYN="N">Quality of Health Care</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>07</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>08</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>1</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26395364</ArticleId>
<ArticleId IdType="doi">10.1111/add.13096</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Harris, Alex H S" sort="Harris, Alex H S" uniqKey="Harris A" first="Alex H S" last="Harris">Alex H S. Harris</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/WillowV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B32 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B32 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= WillowV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:26395364 |texte= The primitive state of quality measures in addiction treatment and their application. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26395364" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a WillowV1
This area was generated with Dilib version V0.6.37. |